Common drug may shield cancer patients from harsh treatment side effects
NCT ID NCT07381634
Summary
This study is testing if ondansetron, a medicine often used for nausea, can help reduce the harmful side effects caused by powerful immunotherapy drugs used to treat liver cancer. It will involve 66 patients who are scheduled to receive standard immunotherapy. Researchers will compare how often and how severe the side effects are in patients who take ondansetron versus those who do not.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR CARCINOMA (HCC) are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.